Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260
Follow us on:
Issue Alert
Issue Alert

June 2026 Issue is Now Live!

 
Warning: Undefined variable $alt_text in /var/www/html/wp-content/themes/RodmanMediaCore/template-parts/newsletter/featured-section.php on line 214

Explore the Full List of Features Now >>
June 2026

Features

Top 20 Pharma and BioPharma Companies

Ranking the Industry’s Leading Companies Shaping the Future of Pharma & BioPharma

Features

Beyond Zero Risk: Rethinking Quality Management in Outsourced Biopharmaceutical Manufacturing

Why pragmatic, risk-based quality systems may offer a smarter path for sponsors and CDMOs than compliance theater and zero-defect thinking.

Features

Bridging the Gap: The LNP Alliance on Translating Nucleic Acid Therapeutics from Lab to Clinic

Experts from the LNP Alliance discuss where LNP programs stall, how the field is moving beyond vaccines, and why translation requires tighter coordination across formulation, characterization, and preclinical testing.

Features

Building Cell Therapy the Right Way

Realize safe, scalable, and compliant cell therapies by building analytical strategies that exceed regulatory expectations.

Features

Building in Success: Integrating QbD Principles in Biologics Formulation Development

Advantages of integrated, QbD-guided formulation development services and key strategies for minimizing risk and maximizing success.

Features

Building in Success: Integrating QbD Principles in Biologics Formulation Development

Advantages of integrated, QbD-guided formulation development services and key strategies for minimizing risk and maximizing success.

Features

Building Successful Viral Vector Production Processes

Practical considerations for scalable manufacturing.

Features

Cell & Gene Therapy CDMO Partnerships

Alliances and expertise behind advancing CGTs in today’s market.

Features

Risk Isn’t Inevitable: How the Right CDMO Partnership Protects Your Program

Why some CDMOs reduce risk while others unintentionally create it.

Features

The Analytical Method Control Strategy

Why analytical method performance depends not only on sample size, but on a lifecycle-based control strategy that understands uncertainty, variability, and risk.

Features

The Future of Biotech Outsourcing

In this Q&A, Ingenza CEO Nick Challoner, discusses how CRDMOs must evolve to help biotech companies accelerate development, reduce risk, and translate scientific innovation into scalable commercial success.